Particle.news

Download on the App Store

Université Laval Confirms Retinal Biomarkers for Early Parkinson’s Detection

New research demonstrates distinct retinal electrophysiological signatures in early Parkinson’s patients and animal models, paving the way for non-invasive early screening.

Image
Image

Overview

  • Université Laval researchers identified unique retinal electrophysiological patterns in early-stage Parkinson’s patients using electroretinography (ERG).
  • Transgenic mice overexpressing human alpha-synuclein exhibited similar retinal impairments before motor symptoms appeared, reinforcing the findings' translational potential.
  • The retina, as a direct extension of the central nervous system, offers a non-invasive method to detect early neurodegenerative changes linked to Parkinson’s disease.
  • The study proposes routine retinal screening from age 50 to enable early detection, monitor disease progression, and evaluate therapeutic efficacy.
  • Further research is underway to validate the specificity of retinal biomarkers across diverse populations and differentiate them from other neurodegenerative disorders.